Business Segment Information

6 Months Ended

Jul. 29, 2023

Segment Reporting [Abstract]

Business Segment Information

Note 10

Business Segment Information

Three Months Ended July 29, 2023
(In thousands)	Journeys Group			Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	287,275		$	122,799	$	77,788		$	35,461		$	—		$	523,323
Intercompany sales		—			—		(3	)		(293	)		—			(296	)
Net sales to external customers(1)		287,275			122,799		77,785			35,168			—			523,027
Segment operating income (loss)		(14,878	)		8,416		2,666			1,851			(8,055	)		(10,000	)
Goodwill impairment(2)		—			—		—			—			28,453			28,453
Asset impairments and other(3)		—			—		—			—			174			174
Operating income (loss)		(14,878	)		8,416		2,666			1,851			(36,682	)		(38,627	)
Other components of net periodic benefit cost		—			—		—			—			148			148
Interest expense, net		—			—		—			—			2,383			2,383
Earnings (loss) from continuing operations before income taxes	$	(14,878	)	$	8,416	$	2,666		$	1,851		$	(39,213	)	$	(41,158	)
Total assets (4)	$	769,844		$	218,913	$	187,379		$	56,977		$	261,646		$	1,494,759
Depreciation and amortization		7,810			1,624		1,137			201			1,061			11,833
Capital expenditures		11,193			3,845		2,097			623			305			18,063

(1) Net sales in North America and in the United Kingdom, which includes the Republic of Ireland, accounted for 77% and 23%, respectively, of our net sales in the second quarter of Fiscal 2024.

(2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

(3) Asset impairments and other includes a $0.2 million charge for asset impairments in Journeys Group.

(4) Of our $720.8 million of long-lived assets, $94.4 million and $14.7 million relate to long-lived assets in the U.K. and Canada, respectively.

Three Months Ended July 30, 2022
(In thousands)	Journeys Group		Schuh Group		Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	321,332	$	101,518	$	74,818	$	37,881		$	—		$	535,549
Intercompany sales		—		—		—		(217	)		—			(217	)
Net sales to external customers(1)		321,332		101,518		74,818		37,664			—			535,332
Segment operating income (loss)		9,222		2,094		3,212		685			(6,002	)		9,211
Asset impairments and other (2)		—		—		—		—			129			129
Operating income (loss)		9,222		2,094		3,212		685			(6,131	)		9,082
Other components of net periodic benefit cost		—		—		—		—			50			50
Interest expense, net		—		—		—		—			405			405
Earnings (loss) from continuing operations before income taxes	$	9,222	$	2,094	$	3,212	$	685		$	(6,586	)	$	8,627
Total assets (3)	$	811,860	$	201,859	$	170,713	$	74,561		$	240,727		$	1,499,720
Depreciation and amortization		6,973		1,532		1,057		217			899			10,678
Capital expenditures		4,333		1,755		1,903		384			5,233			13,608

(1) Net sales in North America and in the United Kingdom, which includes the Republic of Ireland, accounted for 81% and 19%, respectively, of our net sales for the second quarter of Fiscal 2023.

(2) Asset impairments and other includes a $0.1 million charge for asset impairments included in Genesco Brands Group.

(3) Of our $712.2 million of long-lived assets, $93.7 million and $21.5 million relate to long-lived assets in the U.K. and Canada, respectively.

Note 10

Business Segment Information, Continued

Six Months Ended July 29, 2023
(In thousands)	Journeys Group			Schuh Group		Johnston & Murphy Group			Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	559,465		$	215,904	$	160,418		$	71,325		$	—		$	1,007,112
Intercompany sales		—			—		(6	)		(747	)		—			(753	)
Net sales to external customers(1)		559,465			215,904		160,412			70,578			—			1,006,359
Segment operating income (loss)		(33,240	)		6,626		7,472			1,819			(15,366	)		(32,689	)
Goodwill impairment(2)		-			-		-			-			28,453			28,453
Asset impairments and other(3)		—			—		—			—			482			482
Operating income (loss)		(33,240	)		6,626		7,472			1,819			(44,301	)		(61,624	)
Other components of net periodic benefit cost		—			—		—			—			240			240
Interest expense, net		—			—		—			—			4,034			4,034
Earnings (loss) from continuing    operations before income taxes	$	(33,240	)	$	6,626	$	7,472		$	1,819		$	(48,575	)	$	(65,898	)
Depreciation and amortization	$	15,157		$	3,185	$	2,257		$	404		$	2,116		$	23,119
Capital expenditures		24,212			5,996		3,302			1,078			710			35,298

(1) Net sales in North America and in the United Kingdom, which includes the Republic of Ireland, accounted for 79% and 21%, respectively, of our net sales in the first six months of Fiscal 2024.

(2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

(3) Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group.

Six Months Ended July 30, 2022
(In thousands)	Journeys Group		Schuh Group			Johnston & Murphy Group		Genesco Brands Group			Corporate & Other			Consolidated
Sales	$	635,777	$	189,677		$	145,834	$	85,781		$	—		$	1,057,069
Intercompany sales		—		—			—		(989	)		—			(989	)
Net sales to external customers(1)		635,777		189,677			145,834		84,792			—		$	1,056,080
Segment operating income (loss)		24,152		(652	)		3,762		4,478			(14,566	)	$	17,174
Asset impairments and other(2)		—		—			—		—			(154	)		(154	)
Operating income (loss)		24,152		(652	)		3,762		4,478			(14,412	)		17,328
Other components of net periodic benefit cost		—		—			—		—			148			148
Interest expense		—		—			—		—			702			702
Earnings (loss) from continuing    operations before income taxes	$	24,152	$	(652	)	$	3,762	$	4,478		$	(15,262	)	$	16,478
Depreciation and amortization	$	14,211	$	3,122		$	2,179	$	478		$	1,239		$	21,229
Capital expenditures		10,901		3,873			3,809		663			9,759			29,005

(1) Net sales in North America and in the United Kingdom, which includes the Republic of Ireland, accounted for 82% and 18%, respectively, of our net sales for the first six months of Fiscal 2023.

(2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.